Innovaderm's Company Updates and News

Please welcome our new COO!

We are beyond proud to introduce Dave Selkirk as our new Chief Operating Officer. Dave joins @Innovaderm Research Inc. with 29 years of pharma R&D experience, including a decade in key senior positions within a #CRO environment. “I am excited to start my role in this fast-growing organization that is a leader in the transformation of clinical research. I […]

Meet Mary Laccona, new Project Director

Meet @mary george laccona, new Project Director, who will support the @Innovaderm team in the management of global phase III #dermatology trials. Mary has more than 20 years of experience in large international programs in a variety of indications. In addition to her strong project management background, she brings to Innovaderm extensive knowledge of regulatory […]

Innovaderm Supports AnaptysBio at the upcoming National Psoriasis Foundation Walk

Innovaderm is thrilled to support AnaptysBio's team at the upcoming NPF walk in San Diego on November 7. Let's raise awareness. Psoriasis is an autoimmune disease that affects 125 million people worldwide. At Innovaderm, we demonstrate our commitment to people living with psoriatic diseases by continuously working to seek medical advancement with our clients. For […]

Collaboration - Dermatology Decentralized Clinical Trials

What do you think about dermatology decentralized clinical trials? Innovaderm is proud to collaborate with Medable in an effort to safely and successfully execute decentralized dermatology trials. Curious to learn more on what we think of the hybrid approach? Please find below the full press release. For more information on our services, visit https://innovaderm.com/full-service-dermatology-cro/   […]

Presentation at the upcoming virtual EADV conference

Dr. Robert Bissonnette our president and Founder, will present at the 2020 EADV Virtual conference from Thursday, October 29 to Saturday, October 31. The Innovaderm Research Inc. team contributed to more than 9 sessions, including 5 Late-breaking news, training forum, industry hubs, symposium, and many other sessions. To view the full conference scientific programme and register, please […]

Innovaderm Welcomes its New Vice-President, Biometrics

We are pleased to announce the addition of Pina D'Angelo to Innovaderm’s management team, as Vice-President, Biometrics. This recent hire supports our strategic commitment towards Biometrics, particularly important in the management of our ongoing phase 3 dermatology clinical programs. With her extensive experience as an expert in Biostatistics and Data Management, her participation in numerous meetings with […]

Advancing the Development of Imsidolimab with AnaptysBio

We are excited to share some good news! Congratulations AnaptysBio on the orphan drug designation of imsidolimab for the treatment of GPP! We are thrilled to manage this clinical trial and help advance the development of imsidolimab.   For more information on our services, visit https://innovaderm.com/full-service-dermatology-cro/   About Anaptys: AnaptysBio is a clinical-stage antibody development company advancing […]

Innovaderm Moves its Clinical Research Unit Into its new State-of-the-Art Facility

We are thrilled to announce that we recently moved into our new state-of-the-art clinical research unit. As one of the largest dermatology site in North America, we have more than 15 exam rooms, 1 perfusion room, a high volume processing lab and an automated temperature monitoring system (24/7). Thank you L. McComber architecture for working […]